Methotrexate-induced Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder with Diffuse Ground-glass Opacities Diagnosed Using a Cryobiopsy.

Intern MedMar 17, 2026 (epub)

Tetsuya Fujii, Maki Asami-Noyama, Shuichiro Ohata et al.

✦ AI-curated · Sources linked

Case in brief

A 77-year-old woman with rheumatoid arthritis and advanced gastric cancer developed diffuse ground-glass opacities on chest CT and markedly elevated serum lactate dehydrogenase. Intravascular lymphoma was considered. Transbronchial lung cryobiopsy provided tissue for histopathological assessment; after multidisciplinary discussion, the findings were diagnosed as diffuse large B-cell lymphoma associated with methotrexate-induced other iatrogenic immunodeficiency-associated lymphoproliferative disorder.

What made this case unusual

Unlike the pulmonary nodules or masses usually described in methotrexate-associated OIIA-LPD, this case showed diffuse ground-glass opacities. Cryobiopsy enabled the tissue diagnosis.

Diagnostic / clinical pearl

Diffuse ground-glass opacities in a patient receiving methotrexate can accompany OIIA-LPD; tissue sampling may be needed when imaging and clinical findings raise concern for another lymphoma.

Source

Published in Intern Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.